• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

2 Minute Medicine Rewind June 16 – June 23, 2014

byKathleen LiandDavid Ouyang
July 14, 2014
in Cardiology, Chronic Disease, Gastroenterology, Oncology, Public Health, Surgery, Weekly Rewinds
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week.

Loss-of-function Mutations in APOC3, Triglycerides, and Coronary Disease; Loss-of-function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Apolipoprotein C3, a protein in remnant cholesterol particles, is associated with hypertriglyceridemia, which has been associated with increased risk for coronary heart disease. In two observational studies published this week, researchers examined the association between loss-of-function of the APOC3 gene and low TG levels and lower risk of ischemic vascular disease in population studies. In one, investigators identified mutations associated with low TG levels among 3734 participants whose genes were sequenced by the Exome Sequencing Project. Then, they determined the association between mutation carriers and non-carriers and risk of coronary heart disease in 110,970 participants across 15 studies. Loss-of-function mutations in the APOC3 gene(found in 1 in 150 people sequenced) were associated with lower plasma triglycerides than non-carriers (84.5 vs 137.5, p=6×10-9) as well as higher HDL cholesterol levels, and heterozygous carriers of an APOC3 mutation (n=498) had a 40% decreased risk of coronary heart disease compared to non-carriers (OR 0.6, 95%CI 0.47-0.75, p=4×10-6). In another study, researchers used data from prospective population studies in Denmark (n=75,725, median follow up of 34 years) to determine the association between plasma TG levels and risk of ischemic vascular/heart disease, and whether a loss-of-function mutation in APOC3 was also associated with a lower risk of ischemic vascular and heart disease in the same population. Decreasing plasma TG was proportionally associated with a lowered risk for ischemic vascular/heart disease, with participants in the lowest quintile of plasma TG level having approximately half the risk of developing ischemic vascular disease and ischemic heart disease (HR 0.55 and 0.49, respectively) compared to the highest quintile. APOC3 loss-of function mutation carriers (n=302) had on average 44% lower plasma TG levels (p<.001) and significantly lower risk of ischemic vascular and heart disease (HR 0.59, 95%CI 0.41-0.86, p=.007 and HR 0.64, 95%CI 0.41-0.89, p=.04, respectively). Both of these studies suggest that a functional loss of APOC3 may be protective against development of coronary artery and ischemic vascular disease, and thus this protein may be a target for future drug development.

Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection

The current standard for monitoring for rejection after heart transplantation, endomyocardial biopsy, is invasive and costly, and cell-free donor-derived DNA (cfdDNA, measurable in recipient blood and urine), may provide a noninvasive way to monitor the health of the donated organ. In this prospective cohort study, plasma from 65 heart transplant recipients (n=565 samples) was collected and analyzed longitudinally and compared to endomyocardial biopsy results (n=356) to determine the performance of using cfdDNA in measuring transplant rejection. Donor and recipient DNA were differentiated based on pre-transplant SNP genotyping. In 9 rejection-free patients, the proportion of cfdDNA dropped quickly after transplant to a low baseline level of 0.06+0.11% over a follow-up period of 1 year. In comparison, 3 patients who developed acute cellular rejection and/or antibody-mediated rejection had concurrent elevations in cfdDNA. A cfdDNA threshold of 0.25% was 58% sensitive and 93% specific in identifying acute cellular rejection, with an area under the curve (AUC) of 0.83 in receiver operating characteristic analysis. Notably, in 4 of 5 false-positive samples, those patients were subsequently diagnosed with mild rejection within 6 weeks of that sample, suggesting that elevations in cfdDNA may predict rejection before histological evidence of rejection, a potential time window for intervening to prevent more severe organ rejection.

Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults

Evidence for whether increased physical activity prevents or delays reduced mobility in older adults, an independent risk factor for morbidity and mortality, is limited. In this randomized, single-blinded trial (Lifestyle Interventions and Independence for Elders (LIFE)), 1635 sedentary volunteers aged 70-89 from a variety of community settings were assigned to a structured physical activity intervention or a health education program to determine the effect of increased moderate physical activity on losing the ability to walk 400m (major mobility disability) over a 2 year follow-up period. Participants in the physical activity group experienced less major mobility disability (HR 0.82, 95%CI 0.69-0.98, p=.03) and less persistent mobility disability (HR 0.72, 95%CI 0.57-0.91, p=.006) than the control group. Those with lower baseline physical function benefited more from the intervention (HR 0.75 for major mobility disability). The physical activity group had a higher hospitalization rate (not statistically significant) than the control group, counter to expectations based on prior observational cohorts. Overall, the LIFE study demonstrated objective, though modest, benefit of structured physical activity in preventing mobility disability in older adults.

RELATED REPORTS

Plant-based diets may be associated with lower risk of aggressive prostate cancer

Physical activity improves sleep quality and cortisol regulation

Wellness Check: Sleep

Association Between Tumor Necrosis Factor-a Antagonists and Risk of Cancer in Patients with Inflammatory Bowel Disease

Tumor necrosis factor-a (TNF-a) antagonists are effective in treating inflammatory bowel disease (IBD) but may be associated with an increased cancer risk, though long-term follow-up in a large population is needed. In this nationwide prospective cohort study, researchers analyzed data from 56,146 patients with IBD who were followed for a median of 9 years to determine how overall and site-specific cancer rates differed between those who did and did not receive treatment with TNF-a antagonists. Of the 8.1% of IBD patients exposed to TNF-a antagonists, 1.8% developed cancer, compared to 6.7% of unexposed patients (adjusted rate ratio 1.25, 95%CI 1.00-1.58, which decreased to 1.07, 95%CI 0.85-1.36 after further adjusting for azathioprine exposure). Similarly, there was no association between TNF-aantagonist exposure and development of site-specific cancers (including skin cancer, lymphoma, and colorectal cancer) after adjusting for azathioprine exposure, though the number of cases was small. Overall, among a large population of patients with IBD, treatment with TNF-a antagonists in patients with IBD was not observed to be associated with increased risk of malignancy.

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: cancercholesterolexerciseIBDphysical activitytransplant
Previous Post

Obesity linked with prostate cancer progression

Next Post

Cardiac Resynchronization Therapy may be more beneficial in women

RelatedReports

Vegetarian diet may lower incidence of colorectal cancer
Lifestyle

Plant-based diets may be associated with lower risk of aggressive prostate cancer

January 27, 2023
Increased number of daily steps linked with decreased mortality in older women
Endocrinology

Physical activity improves sleep quality and cortisol regulation

January 20, 2023
Decline in adolescent sleep duration over past 20 years
Wellness

Wellness Check: Sleep

January 19, 2023
Certain financial incentive programs may promote increased physical activity
Chronic Disease

Physical activity may be helpful in treating depressive symptoms in children and adolescents

January 18, 2023
Next Post
Cardiac Resynchronization Therapy may be more beneficial in women

Cardiac Resynchronization Therapy may be more beneficial in women

Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy

Adults with Asperger’s syndrome at increased risk for suicidal thoughts and behaviors

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options